Breakthrough for patients who are at high risk from heart attacks, strokes or premature death because it is the first time an oral (diabetes) agent has been shown to have this benefit in a prospective study.

We stuck in all the symptoms that diabetics get, ranging from serious things like death to less serious things like ballooning of the arteries in the legs. While it didn't meet the goal at the combination endpoint, it did on the one that really matters to patients: death, heart attacks and strokes.

This groundbreaking study gives new hope to people with type 2 diabetes who, despite their attempts to control blood glucose and take medications, fear these life-threatening events.